ATE423199T1 - Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik - Google Patents

Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik

Info

Publication number
ATE423199T1
ATE423199T1 AT02743820T AT02743820T ATE423199T1 AT E423199 T1 ATE423199 T1 AT E423199T1 AT 02743820 T AT02743820 T AT 02743820T AT 02743820 T AT02743820 T AT 02743820T AT E423199 T1 ATE423199 T1 AT E423199T1
Authority
AT
Austria
Prior art keywords
human thrombin
prethrombin
human
producing human
thrombin
Prior art date
Application number
AT02743820T
Other languages
English (en)
Inventor
Hiroshi Yonemura
Takayuki Imamura
Hiroshi Nakatake
Kenji Soejima
Chikateru Nozaki
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE423199T1 publication Critical patent/ATE423199T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT02743820T 2001-07-06 2002-07-04 Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik ATE423199T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001206919 2001-07-06

Publications (1)

Publication Number Publication Date
ATE423199T1 true ATE423199T1 (de) 2009-03-15

Family

ID=19042979

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02743820T ATE423199T1 (de) 2001-07-06 2002-07-04 Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik

Country Status (9)

Country Link
US (1) US7635577B2 (de)
EP (1) EP1405910B1 (de)
JP (1) JP4227012B2 (de)
KR (2) KR100983878B1 (de)
CN (1) CN100347297C (de)
AT (1) ATE423199T1 (de)
CA (1) CA2452768C (de)
DE (1) DE60231210D1 (de)
WO (1) WO2003004641A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040219140A1 (en) * 2001-02-22 2004-11-04 Reiner Class Compositions and methods for preventing platelet aggregation
WO2005010178A1 (ja) 2003-07-29 2005-02-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 組換えフィブリノゲン高産生細胞の作製方法及び高産生細胞
GB0324044D0 (en) * 2003-10-14 2003-11-19 Astrazeneca Ab Protein
EP1676911B1 (de) 2003-10-24 2010-04-21 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Neue rekombinante tierzellen mit hoher proteinproduktion, verfahren zur konstruktion davon sowie verfahren zur massenproduktion von protein unter verwendung davon
MXPA06013698A (es) * 2004-05-24 2007-08-15 Panacos Pharmaceuticals Inc Inhibicion de replicacion de virus 1 de inmunodeficiencia humana (vih-1) por interrupcion del procesamiento de la proteina de capsida-peptido separador 1 viral.
EP1874928A1 (de) * 2005-04-13 2008-01-09 AstraZeneca AB Wirtszelle mit vektor zur herstellung von gamma-carboxylierung benötigenden proteinen
EP1939283A4 (de) 2005-09-30 2009-02-25 Chemo Sero Therapeut Res Inst Verfahren zur produktion von rekombinantem menschlichem thrombin durch eine kultivierte zelle
US20100159512A1 (en) * 2006-03-06 2010-06-24 Kurt Osther Method for the preparation of recombinant human thrombin and fibrinogen
US8206967B2 (en) * 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
AU2009236960A1 (en) 2008-04-16 2009-10-22 The Chemo-Sero-Therapeutic Research Institute Method of producing thrombin-immobilized bioabsorbable sheet preparation
JPWO2014103608A1 (ja) 2012-12-25 2017-01-12 一般財団法人化学及血清療法研究所 HPV/HBsキメラタンパク質を有効成分とするHPV感染症及び/又はB型肝炎用ワクチン
JP6216647B2 (ja) 2013-03-15 2017-10-18 シスメックス株式会社 組換え型プロトロンビンの製造方法およびその利用
WO2025208342A1 (zh) * 2024-04-02 2025-10-09 苏州泽璟生物制药股份有限公司 高纯度且低残留的重组人凝血酶制备方法及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2824434B2 (ja) * 1989-11-28 1998-11-11 財団法人化学及血清療法研究所 新規発現ベクター
US5278144A (en) 1990-09-04 1994-01-11 Cor Therapeutics, Inc. Antithrombosis agents
US5583107A (en) 1990-09-04 1996-12-10 Cor Therapeutics, Inc. Agents affecting thrombosis and hemostasis
CA2078721A1 (en) * 1991-09-24 1993-03-25 Hiroshi Yonemura Process for preparing human coagulation factor viii protein complex
JP3168087B2 (ja) * 1993-01-11 2001-05-21 株式会社ヤスヰ 洗車方法及びその装置
AT404357B (de) 1995-06-13 1998-11-25 Immuno Ag Prothrombin-derivate
JP2002514433A (ja) 1998-05-14 2002-05-21 バッテル メモリアル インスティテュート トランスジェニック植物由来ヒト凝血因子
JP2003504082A (ja) 1999-07-09 2003-02-04 コヘージョン テクノロジーズ, インコーポレイテッド エカリンポリペプチド、エカリンをコードするポリヌクレオチド、及びその利用のための方法
CN1298017A (zh) * 1999-11-29 2001-06-06 中国科学技术大学 一种快速活化凝血酶原的方法

Also Published As

Publication number Publication date
CN1551917A (zh) 2004-12-01
KR20090087136A (ko) 2009-08-14
EP1405910B1 (de) 2009-02-18
WO2003004641A1 (en) 2003-01-16
US7635577B2 (en) 2009-12-22
CA2452768A1 (en) 2003-01-16
DE60231210D1 (de) 2009-04-02
EP1405910A4 (de) 2005-02-02
KR20040032147A (ko) 2004-04-14
EP1405910A1 (de) 2004-04-07
JP4227012B2 (ja) 2009-02-18
KR100983878B1 (ko) 2010-09-27
CA2452768C (en) 2011-06-07
CN100347297C (zh) 2007-11-07
US20040197858A1 (en) 2004-10-07
JPWO2003004641A1 (ja) 2004-10-28

Similar Documents

Publication Publication Date Title
ATE423199T1 (de) Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik
ATE466094T1 (de) Verfahren zur herstellung von oligosacchariden
ATE420192T1 (de) Verfahren zur verringerung der antigenität des adeno-assoziierten virus strukturproteins
ATE346835T1 (de) Verfahren zur herstellung von acrolein und/oder acrylsäure
ATE393632T1 (de) Transfektion von blutzellen mit mrna zur immunstimulation und gentherapie
DE69634043D1 (de) Zirkuläres dna molekül mit einem abhängigen replikationsursprung, seine herstellungsverfahren und seine verwendung in der gentherapie
ATE469223T1 (de) Pilz transkriptionsaktivator zur verwendung in verfahren zur herstellung von polypeptiden
ATE439437T1 (de) Verbessertes klonierungsverfahren
NO942456L (no) Fremgangsmåte for fremstilling av trombin
RU2008139428A (ru) Способ получения рекомбинантного тромбина и фибриногена человека
DE60229636D1 (de) Verfahren zur reinigung von zellen
DE60028777D1 (de) Verfahren zur herstellung von 1,3-propanediol durch einen rekombinanten micro-organismus in abwesenheit von coenzym b12
ATE464379T1 (de) Saatspezifische usp-promotoren zur expression von genen in pflanzen
RU2012130928A (ru) Способ культивирования адгезионных клеток
ATE420868T1 (de) Verbessertes verfahren zur herstellung von ethylenoxid
ATE542913T1 (de) Promotorvarianten zur expression von genen in einer pilzzelle
Tonti et al. Neural stem cells at the crossroads: MMPs may tell the way
DE60225312D1 (de) Samenspezifische 7s-alpha-promoter zur expression von genen in pflanzen
ATE462013T1 (de) Verfahren zur kultivierung von zellen zur produktion von substanzen
NL960017I2 (nl) Expressie van Factor VIII-activiteit in zoogdiercellen.
DE69623122D1 (de) Methode zur expression in und isolation von biologisch aktiven molekülen aus urin
JPS60500043A (ja) 原核細胞又は真核細胞中で合成される融合蛋白質から成熟蛋白質を作る方法
JP2005517404A5 (de)
EP1589102A4 (de) Gensequenz für l-rhamnose-isomerase mit neuer katalytischer funktion und verwendung davon
ATE341630T1 (de) Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1405910

Country of ref document: EP